Free Trial

Sonnet BioTherapeutics (SONN) Earnings Date, Estimates & Call Transcripts

$0.86
+0.01 (+1.18%)
(As of 07/26/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 12Estimated
Actual EPS
(May. 14)
$0.07 Beat By $0.07
Skip Charts & View Estimated and Actual Earnings Data

SONN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SONN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Sonnet BioTherapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($2.14) EPS
Next Year EPS Consensus Estimate: ($2.52) EPS

SONN Earnings Date and Information

Sonnet BioTherapeutics last announced its earnings data on May 14th, 2024. The reported $0.07 EPS for the quarter. Sonnet BioTherapeutics has generated $0.00 earnings per share over the last year. Earnings for Sonnet BioTherapeutics are expected to decrease in the coming year, from ($2.14) to ($2.52) per share. Sonnet BioTherapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off prior year's report dates.

Sonnet BioTherapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/12/2024
(Estimated)
------- 
5/14/2024Q2 2024-$0.07+$0.07$0.07--
2/14/2024Q1 2024-($0.31)($0.31)($0.31)-$0.02 million
8/14/2023Q3 2023-($2.86)($2.86)($0.13)-$0.04 million
5/10/2023Q2 2023-($7.48)($7.48)($0.34)-$0.04 million
2/13/2023Q1 2023($24.20)($17.60)+$6.60($0.80)-$0.04 million
8/15/2022Q3 2022-($40.04)($40.04)($0.13)-$0.06 million
5/10/2022Q2 2022-($43.12)($43.12)($0.14)-$0.10 million
2/8/2022Q1 2022($92.40)($30.80)+$61.60($0.10)-$0.13 million
8/16/2021Q3 2021-($83.16)($83.16)($0.27)--
5/17/2021Q2 2021-($98.56)($98.56)($0.32)--
2/16/2021Q4 2020-($104.72)($104.72)($0.34)--
12/17/2020Q4 2020-($1,456.84)($1,456.84)($4.73)--
8/14/2020Q2 2020-($135.52)($135.52)$0.17--
5/18/2020Q1 2020-($15.40)($15.40)($0.05)-$0.01 million
11/14/2019Q3 2019($1,598.52)($1,441.44)+$157.08$0.77$10.22 million$9.65 million
8/14/2019Q2 2019($2,399.32)($4,000.92)($1,601.60)($4.42)$11.17 million$10.71 million

Sonnet BioTherapeutics Earnings - Frequently Asked Questions

When is Sonnet BioTherapeutics's earnings date?

Sonnet BioTherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates. Learn more on SONN's earnings history.

How much revenue does Sonnet BioTherapeutics generate each year?

Sonnet BioTherapeutics (NASDAQ:SONN) has a recorded annual revenue of $150,000.00.

How much profit does Sonnet BioTherapeutics generate each year?

Sonnet BioTherapeutics (NASDAQ:SONN) has a recorded net income of -$18.83 million. SONN has generated $0.00 earnings per share over the last four quarters.

What is Sonnet BioTherapeutics's EPS forecast for next year?

Sonnet BioTherapeutics's earnings are expected to decrease from ($2.14) per share to ($2.52) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:SONN) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners